Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Feb;43(2):246–253.

Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.

N Anh-Tuan, E Novák
PMCID: PMC1537276  PMID: 7273479

Abstract

The PEG-trypsinization assay detected HBsAg-CICs in 31 out of 44 (70%) patients with acute hepatitis B, in five out of 107 (5%) asymptomatic HBsAg carriers and, in addition, in both patients with HBsAg-positive chronic liver disease. A close correlation between the levels of HBsAg-CICs and disease activity was observed. The clinical course, parameters of liver function tests and outcome of the disease in patients without HBsAg-CICs (group A) and in patients with transient HBsAg-CICs (group B) were essentially similar. In contrast, patients with persistent HBsAg-CICs (group C) had a poor prognosis, particularly those who received corticosteroids. The method appeared to be a valuable tool in monitoring disease activity and prognosis, and in evaluating the efficacy of corticosteroid treatment. The role of HBsAg-CICs in the pathogenesis of liver damage and clearance of circulating HBsAg is discussed.

Full text

PDF
246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  2. Anh-Tuan N., Novák E. Detection and quantitation of hepatitis-B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. I. Detection and quantitation of in vitro prepared HBsAg-ICs. J Immunol Methods. 1980;33(3):293–300. doi: 10.1016/0022-1759(80)90216-1. [DOI] [PubMed] [Google Scholar]
  3. Bedarida G., Zacchi T., Tassi G. C. Preliminary observations on Au-anti-Au immune complex research by a modified electrosyneresis method. Boll Ist Sieroter Milan. 1971 Mar-Apr;50(2):74–82. [PubMed] [Google Scholar]
  4. Brzosko W. J., Madalinski K., Krawczynski K., Skwarska H., Nowoslawski A. Australia antigen immune complexes in patients with different forms of hepatitis. J Infect Dis. 1971 Mar;123(3):251–256. doi: 10.1093/infdis/123.3.251. [DOI] [PubMed] [Google Scholar]
  5. Carella G., Digeon M., Feldmann G., Jungers P., Drouet J., Bach J. F. Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis. Scand J Immunol. 1977;6(12):1297–1304. doi: 10.1111/j.1365-3083.1977.tb00369.x. [DOI] [PubMed] [Google Scholar]
  6. De Groote J., Fevery J., Lepoutre L. Long-term follow-up of chronic active hepatitis of moderate severity. Gut. 1978 Jun;19(6):510–513. doi: 10.1136/gut.19.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  8. Fresco G. F. Detection of circulating immune complexes in hepatitis by means of a new method employing 125i-antibody. circulating immune complexes in hepatitis. Acta Hepatogastroenterol (Stuttg) 1978 Jun;25(3):185–188. [PubMed] [Google Scholar]
  9. GROSS L. IMMUNOLOGICAL DEFECT IN AGED POPULATION AND ITS RELATIONSHIP TO CANCER. Cancer. 1965 Feb;18:201–204. doi: 10.1002/1097-0142(196502)18:2<201::aid-cncr2820180211>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  10. Madaliński K., Sztachelska-Budkowska A., Brzosko W. J. DEAE-cellulose chromatography: a method for dissociation of soluble immune complexes of hepatitis B antigen. J Infect Dis. 1974 Apr;129(4):371–375. doi: 10.1093/infdis/129.4.371. [DOI] [PubMed] [Google Scholar]
  11. Millman I., London W. T., Sutnick A. I., Blumberg B. S. Australia antigen-antibody complexes. Nature. 1970 Apr 4;226(5240):83–84. doi: 10.1038/226083a0. [DOI] [PubMed] [Google Scholar]
  12. Pernice W., Sedlacek H. H. Antigen-specific detection of soluble immune complexes by a solid phase specific antibody system. J Immunol Methods. 1979;28(1-2):33–40. doi: 10.1016/0022-1759(79)90325-9. [DOI] [PubMed] [Google Scholar]
  13. Pesendorfer F., Krassnitzky O., Wewalka F. Immunelektrophoretischer Nachweis von "Hepatitis-Associated-Antigen" (Au-SH-Antigen. Klin Wochenschr. 1970 Jan 1;48(1):58–59. doi: 10.1007/BF01486135. [DOI] [PubMed] [Google Scholar]
  14. Santoro F., Wattre P., Dessaint J. P., Capron A. Hepatitis B circulating immune complexes. Characterization by radioimmunoprecipitation--PEG assay (RIPEGA). J Immunol Methods. 1977;15(3):201–209. doi: 10.1016/0022-1759(77)90057-6. [DOI] [PubMed] [Google Scholar]
  15. Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969 Jul 18;165(3890):304–306. doi: 10.1126/science.165.3890.304. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES